Asthma remission one, none and one-hundred thousand: the relevance of the patient’s view

Bonini, Matteo;Barbaglia, Simona;Camiciottoli, Gianna;Del Giacco, Stefano;Di Marco, Fabiano;Matucci, Andrea;Micheletto, Claudio;Papi, Alberto;Pasqualetti, Patrizio;Pelaia, Girolamo;Ricciardolo, Fabio Luigi Massimo;Rogliani, Paola;Senna, Gianenrico;Triggiani, Massimo;Vancheri, Carlo;Canonica, Giorgio Walter

2024-01-01

---

Abstract

ObjectiveAchieving remission in severe asthma holds paramount importance in elevating patient quality of life and reducing both individual and societal burdens associated with this chronic condition. This study centers on identifying pivotal patient-relevant endpoints through standardized, reproducible methods, while also developing a patient-centric definition of remission, essential for effective disease management.MethodsA discrete choice experiment (DCE) was conducted to assess patients' perceptions on the four primary criteria for defining severe asthma remission, as outlined by the SANI survey. Additionally, it investigated the correlation between these perceptions and improvements in the doctor-patient therapeutic alliance during treatment decision-making.Results249 patients (70% aged between 31-60, 59% women and 82% without other pathologies requiring corticosteroids) prioritize the use of oral corticosteroids (OCS, 48%) and the Asthma Control Test (ACT, 27%) in defining their condition, ranking these above lung function and exacerbations. This preference for OCS stems from its direct role in treatment, tangible tracking, immediate symptom relief, and being a concrete measure of disease severity compared to the less predictable and quantifiable exacerbations.ConclusionsThis study explores severe asthma remission from patients' perspectives using clinician-evaluated parameters. The DCE revealed that most patients highly value OCS and the ACT, prefer moderate improvement, and avoid cortisone cycles. No definitive preference was found for lung function status. Integrating patient-reported information with professional insights is crucial for effective management and future research. Personalized treatment plans focusing on patient preferences, adherence, and alternative therapies aim to achieve remission and enhance quality of life.